Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic Alopecia
— · Androgenetic Alopecia (AGA), Healthy Volunteers - Male and Female · Recruiting · est. 2028-07
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Absci is lead sponsor; 1 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 10-Q2026-08-11Quarterly report
- 8-K2026-08-11Current report (material event)
- 8-K2026-06-24Current report (material event)
- 424B52026-06-24Prospectus (offering)
- 8-K2026-06-24Current report (material event)
- 8-K2026-06-05Current report (material event)
- 10-Q2026-05-07Quarterly report
- 8-K2026-05-07Current report (material event)
- ARS2026-04-22Annual report to holders
- DEFA14A2026-04-22DEFA14A
- DEF 14A2026-04-22Proxy statement
- SCHEDULE 13D/A2026-04-14SCHEDULE 13D/A
- SCHEDULE 13D/A2026-03-26SCHEDULE 13D/A
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- S-82026-03-24Employee stock plan
- 10-K2026-03-24Annual report
- 8-K2026-03-24Current report (material event)
- 8-K2026-03-06Current report (material event)
- SCHEDULE 13G2026-01-30SCHEDULE 13G
- 8-K2026-01-14Current report (material event)
- SCHEDULE 13G/A2025-11-13SCHEDULE 13G/A
- 10-Q2025-11-12Quarterly report
- 8-K2025-11-12Current report (material event)
- 8-K2025-11-04Current report (material event)
- SCHEDULE 13G/A2025-10-30SCHEDULE 13G/A
- EFFECT2025-08-22EFFECT
- 424B32025-08-22424B3
- CORRESP2025-08-20CORRESP
- UPLOAD2025-08-19UPLOAD
- 8-K/A2025-08-12Current report (amended)
- S-32025-08-12Shelf registration
- 10-Q2025-08-12Quarterly report
- 8-K2025-08-12Current report (material event)
- SCHEDULE 13G2025-07-29SCHEDULE 13G
- 424B52025-07-25Prospectus (offering)
- 8-K2025-07-25Current report (material event)
- 424B52025-07-24Prospectus (offering)
- SCHEDULE 13G/A2025-07-16SCHEDULE 13G/A
- 8-K2025-07-08Current report (material event)
- 8-K2025-06-12Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.